Meeder Asset Management Inc. Invests $5.70 Million in CVS Health Corporation $CVS

Key Points

• Meeder Asset Management purchased 55,105 CVS Health shares worth approximately $5.7 million during the second quarter. Institutional investors and hedge funds collectively own 80.66% of the company.
• Analysts remain broadly positive, with 22 Buy ratings and two Holds, a “Moderate Buy” consensus, and an average price target of $106.75. Several firms recently raised their targets, including JPMorgan to $118.
• CVS reported quarterly earnings of $2.58 per share, beating estimates of $1.87, while revenue rose 7.3% year over year to $106.1 billion. The company maintains a quarterly dividend of $0.665 per share, or $2.66 annually.

Meeder Asset Management Inc. bought a new position in CVS Health Corporation (NYSE:CVS - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 55,105 shares of the pharmacy operator's stock, valued at approximately $5,701,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Sei Investments Co. boosted its holdings in shares of CVS Health by 17.4% in the second quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator's stock worth $62,474,000 after buying an additional 134,535 shares during the period. The Manufacturers Life Insurance Company raised its holdings in shares of CVS Health by 1.2% during the second quarter. The Manufacturers Life Insurance Company now owns 1,121,377 shares of the pharmacy operator's stock valued at $77,353,000 after acquiring an additional 13,329 shares during the period. Treasurer of the State of North Carolina lifted its position in shares of CVS Health by 1.3% in the 2nd quarter. Treasurer of the State of North Carolina now owns 585,073 shares of the pharmacy operator's stock valued at $40,358,000 after acquiring an additional 7,588 shares in the last quarter. HUB Investment Partners LLC boosted its stake in CVS Health by 25.0% in the 2nd quarter. HUB Investment Partners LLC now owns 15,063 shares of the pharmacy operator's stock worth $1,039,000 after purchasing an additional 3,011 shares during the period. Finally, Alliancebernstein L.P. boosted its stake in CVS Health by 8.0% in the 2nd quarter. Alliancebernstein L.P. now owns 1,609,404 shares of the pharmacy operator's stock worth $111,017,000 after purchasing an additional 119,439 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

Get CVS Health SMS alerts:

Sign Up

Insider Buying and Selling at CVS Health

In other news, Director Larry Robbins sold 370,462 shares of the firm's stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $93.45, for a total transaction of $34,619,673.90. Following the completion of the sale, the director directly owned 4,824,799 shares of the company's stock, valued at $450,877,466.55. This trade represents a 7.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.85% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Barclays boosted their target price on shares of CVS Health from $106.00 to $108.00 and gave the company an "overweight" rating in a research note on Thursday, August 6th. JPMorgan Chase & Co. raised their target price on CVS Health from $111.00 to $118.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 12th. Argus upped their price target on CVS Health from $90.00 to $104.00 and gave the company a "buy" rating in a research report on Thursday, May 14th. TD Cowen increased their price objective on CVS Health from $105.00 to $110.00 and gave the stock a "buy" rating in a research note on Monday, May 11th. Finally, Wall Street Zen upgraded CVS Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 8th. Twenty-two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $106.75.

CVS Health Trading Down 3.3%

Shares of NYSE:CVS opened at $93.99 on Tuesday. The firm has a fifty day moving average of $102.46 and a two-hundred day moving average of $88.41. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 12-month low of $69.40 and a 12-month high of $110.68. The firm has a market capitalization of $120.21 billion, a P/E ratio of 24.87, a price-to-earnings-growth ratio of 0.93 and a beta of 0.61.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts' consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same period in the prior year, the business posted $1.81 earnings per share. CVS Health's revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, equities analysts expect that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health's dividend payout ratio is presently 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source